Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
77.9 EUR | +0.39% | +5.56% | -8.57% |
May. 02 | Argan: Mr. Le Lan and Kerlan below 30% of share capital & voting rights | CF |
Apr. 25 | Invest Securities Keeps Argan at Neutral, Raises PT | MT |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company's share price in relation to its net book value makes it look relatively cheap.
- This company will be of major interest to investors in search of a high dividend stock.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commercial REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.57% | 1.93B | C | ||
-21.48% | 96.91B | B+ | ||
+35.89% | 42.72B | B- | ||
-21.02% | 9.63B | A- | ||
-13.60% | 7.62B | B | ||
-25.57% | 6.4B | B | ||
-11.39% | 6.33B | B- | ||
-10.82% | 6.22B | B- | ||
-7.37% | 6.12B | B | ||
-13.67% | 5.22B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ARG Stock
- Ratings Argan